GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Most Recent Videos

How Apple Conquered China Market: Bloomberg West (01/30)
32:52 - Jan. 30 -- Full episode of "Bloomberg West." Guests: GGV Capital's Hans Tung, Strategic Analytics' Neil Mawston, Evercore ISI's Ken Sena, CKE Restaurants CEO Andrew Puzder, Boost VC CEO Adam Draper and Zebra Technologies' Jill Stelfox.
  • Should Amazon Spin Off Its Growing Cloud Business?
  • TripAdvisor's Top Pick: Chicago's Langham Hotel
  • Dan Marino: Roger Goodell Has Done a Really Good Job